Bioactivities of quinoides 1–5 and VEGFR2 TKIs 6–10 in hepatocellular cancer (HCC) and cancer stem cells (HCSCs) were studied. Quinoide 3 was able to eradicate cancer stem cells.
醌类化合物1-5和V
EGFR2 TKIs 6-10在肝细胞癌(HCC)和癌干细胞(HCSCs)中的
生物活性进行了研究。
醌类化合物3能够根除癌干细胞。